MONETABRIEF – Sri Lanka's Sunshine Holdings Plc, which has interests in health care and consumer goods, said it had agreed with India's Zydus Life Sciences Limited to set up a 20 million US dollar pharmaceuticals factory in the South Asian island.
The "GMP-compliant oral solid dosage pharmaceutical" factory will be built in the Horana Export Processing Zone operated by the Board of Investment, Sunshine said in a stock exchange filing.
The company will operate as Zydus Sunshine Lifesciences (Private) Ltd.
Zydus employed 30,000 people, and 1,500 scientists engaged in research and development.
Zydus has interest in active pharmaceutical ingredients (APIs), medical technology, diagnostics, animal healthcare and consumer wellness, Sunshine said. (Colombo/June29/2026)